WO2026062564 - COMPOSITIONS AND METHODS FOR INITIATING A MUCOSAL IMMUNE RESPONSE
National phase entry is expected:
Publication Number
WO/2026/062564
Publication Date
26.03.2026
International Application No.
PCT/IB2025/059397
International Filing Date
19.09.2025
Title **
[English]
COMPOSITIONS AND METHODS FOR INITIATING A MUCOSAL IMMUNE RESPONSE
[French]
COMPOSITIONS ET MÉTHODES POUR INITIER UNE RÉPONSE IMMUNITAIRE MUCOSALE
Applicants **
IX BIOPHARMA LIMITED
Inventors
LIM, Chin Beng Stephen
LEE, Yip Hang Eddy
COOK, Iain Bruce
Priority Data
2024902997
19.09.2024
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2995 | |
| EPO | Filing, Examination, Granting | 17554 | |
| Japan | Filing, Examination, Granting | 2368 | |
| South Korea | Filing, Examination, Granting | 2497 | |
| USA | Filing, Examination, Granting | 8990 |
Total:
34,404
Contact Us
Abstract[English]
The present invention relates to compositions comprising a biological active material. The present invention also relates to pharmaceutical compositions, dosage forms and methods for initiating a mucosal immune response.[French]
La présente invention concerne des compositions comprenant un matériau biologiquement actif. La présente invention concerne également des compositions pharmaceutiques, des formes galéniques et des méthodes pour initier une réponse immunitaire mucosale.